Effect of Intravenous Tirofiban Versus Placebo on First-Pass Successful Reperfusion in Endovascular Stroke Thrombectomy: Insights From the RESCUE BT Randomized Clinical Trial.

In our study, the rate of increased FPSR with intravenous tirofiban was nominally higher among patients with stroke due to large‐artery atherosclerosis rather than cardioembolism or other pathogeneses, though this difference did not reach statistical significance.

also in 111,027 other papers